Medications for Polycythemia Vera
3 results
Besremi (ropeginterferon alfa-2b)
(ropeginterferon alfa-2b)Pharmaessentia Usa Corporation
Usage: BESREMi is indicated for the treatment of adults with polycythemia vera.
Jakafi (ruxolitinib)
(ruxolitinib)Incyte Corporation
Usage: Jakafi is indicated for treating intermediate or high-risk myelofibrosis, polycythemia vera in adults intolerant to hydroxyurea, and steroid-refractory acute graft-versus-host disease in patients aged 12 and older. It also treats chronic graft-versus-host disease after failure of one or two prior systemic therapies in the same age group.
P32 sodium phosphate (p32 sodium phosphate)
(P32 Sodium Phosphate)AnazaoHealth Corporation
Usage: P32 sodium phosphate is indicated for treating polycythemia vera and is effective in chronic myelocytic and chronic lymphocytic leukemia. It may also be used palliatively in selected patients with multiple skeletal metastases.